Inventor · disambiguated record
Stephanie Staelens
Also filed as: STAELENS STEPHANIE
22 granted patents·17 pending applications·113 citations·filing 2009–2025
95Inventor score
Files withABLYNX NV27BOEHRINGER INGELHEIM INT4NOVARTIS AG2REVETS HILDE ADI PIERRETTE2BAUMEISTER JUDITH1
Top patents by PatentIndex Score
39 records- 0197US10858418B2Techniques for predicting, detecting and reducing aspecific protein interference in assays involving immunoglobulin single variable domainsABLYNX NV·Filed 2020·Granted Dec 8, 2020·18 cites·20 claims
- 0292US11192937B2Techniques for predicting, detecting and reducing aspecific protein interference in assays involving immunoglobulin single variable domainsABLYNX NV·Filed 2017·Granted Dec 7, 2021·5 cites·6 claims
- 0392US11192938B2Serum albumin binding proteins containing immunoglobulin single variable domainsABLYNX NV·Filed 2017·Granted Dec 7, 2021·5 cites·35 claims
- 0491US11414481B2Serum albumin bindersABLYNX NV·Filed 2018·Granted Aug 16, 2022·6 cites·22 claims
- 0590US8962807B2Single variable domain antibodies against OX40L, constructs and therapeutic useVERDONCK FRANK·Filed 2010·Granted Feb 24, 2015·27 cites·20 claims
- 0689US11952418B2Biparatopic polypeptides antagonizing Wnt signaling in tumor cellsBOEHRINGER INGELHEIM INT·Filed 2020·Granted Apr 9, 2024·2 cites·3 claims
- 0788US8217140B2Peptides capable of binding to serum proteins and compounds, constructs and polypeptides comprising the sameREVETS HILDE ADI PIERRETTE·Filed 2009·Granted Jul 10, 2012·11 cites·18 claims
- 0887US9328174B2Chemokine receptor binding polypeptidesNOVARTIS AG·Filed 2013·Granted May 3, 2016·8 cites·11 claims
- 0986US8945567B2Monovalent, bivalent and trivalent anti human respiratory syncytial virus (HRSV) nanobody constructs for the prevention and/or treatment of respiratory tract infectionsDEPLA ERIK·Filed 2010·Granted Feb 3, 2015·8 cites·8 claims
- 1085US12006352B2Techniques for predicting, detecting and reducing aspecific protein interference in assays involving immunoglobulin single variable domainsABLYNX NV·Filed 2020·Granted Jun 11, 2024·1 cites·6 claims
- 1185US11414480B2Serum albumin binding immunoglobulin single variable domainsABLYNX NV·Filed 2017·Granted Aug 16, 2022·6 cites·20 claims
- 1285US2023242620A1Techniques for predicting, detecting and reducing aspecific protein interference in assays involving immunoglobulin single variable domainsABLYNX NV·Filed 2023·Application pending·0 cites
- 1383US11033636B2Polypeptides antagonizing Wnt signaling in tumor cellsBOEHRINGER INGELHEIM INT·Filed 2018·Granted Jun 15, 2021·2 cites·9 claims
- 1482US10597449B2Biparatopic polypeptides antagonizing Wnt signaling in tumor cellsBOEHRINGER INGELHEIM INT·Filed 2016·Granted Mar 24, 2020·4 cites·13 claims
- 1582US9803001B2Monovalent, bivalent and trivalent anti human respiratory syncytial virus (hRSV) nanobody constructs for the prevention and/or treatment of respiratory tract infectionsABLYNX NV·Filed 2014·Granted Oct 31, 2017·4 cites·6 claims
- 1681US11644471B2Techniques for predicting, detecting and reducing aspecific protein interference in assays involving immunoglobulin single variable domainsABLYNX NV·Filed 2013·Granted May 9, 2023·2 cites·9 claims
- 1776US11897944B2Immunoglobulin single variable domain (ISVD) capable of binding to serum albuminABLYNX NV·Filed 2018·Granted Feb 13, 2024·1 cites·16 claims
- 1876US9834611B2Single variable domain antibodies against OX40L, constructs and therapeutic useABLYNX NV·Filed 2014·Granted Dec 5, 2017·2 cites·20 claims
- 1972US2024294617A1Serum albumin bindersABLYNX NV·Filed 2024·Application pending·0 cites
- 2071US9688763B2Chemokine receptor binding polypeptidesNOVARTIS AG·Filed 2015·Granted Jun 27, 2017·1 cites·10 claims
- 2171US2025345448A1Polypeptides antagonizing wnt signaling in tumor cellsABLYNX NV·Filed 2025·Application pending·0 cites
- 2268US12285493B2Polypeptides antagonizing Wnt signaling in tumor cellsBOEHRINGER INGELHEIM INT·Filed 2021·Granted Apr 29, 2025·0 cites·8 claims
- 2366US2018355031A1Techniques for predicting, detecting and reducing aspecific protein interference in assays involving immunoglobulin single variable domainsABLYNX NV·Filed 2018·Application pending·0 cites
- 2466US2024132624A1Polypeptides binding to a specific epitope of the neonatal fc receptorABLYNX NV·Filed 2023·Application pending·0 cites
- 2566US2023060574A1Serum albumin bindersABLYNX NV·Filed 2022·Application pending·0 cites
- 2665US2025296991A1Precision activated polypeptidesABLYNX NV·Filed 2024·Application pending·0 cites
- 2764US11028151B2Monovalent, bivalent and trivalent anti human respiratory syncytial virus (HRSV) nanobody constructs for the prevention and/or treatment of respiratory tract infectionsABLYNX NV·Filed 2017·Granted Jun 8, 2021·0 cites·11 claims
- 2864US2022242958A1Bispecific nanobodiesABLYNX NV·Filed 2021·Application pending·0 cites
- 2963US2024109965A1Immunoglobulin single variable domains targeting t cell receptorABLYNX NV·Filed 2023·Application pending·0 cites
- 3062US2018009888A9Techniques for predicting, detecting and reducing aspecific protein interference in assays involving immunoglobulin single variable domainsBAUMEISTER JUDITH·Filed 2012·Application pending·0 cites
- 3162US2023050615A1Improved serum albumin binding immunoglobulin single variable domainsABLYNX NV·Filed 2022·Application pending·0 cites
- 3261US10822425B2Single variable domain antibodies against OX40L, constructs and therapeutic useABLYNX NV·Filed 2017·Granted Nov 3, 2020·0 cites·15 claims
- 3357US2024092919A1T cell recruiting polypeptides based on tcr alpha/beta reactivityABLYNX NV·Filed 2021·Application pending·0 cites
- 3454US11466089B2Chemokine receptor binding polypeptidesABLYNX NV·Filed 2017·Granted Oct 11, 2022·0 cites·10 claims
- 3551US2016251440A1Bispecific nanobodiesABLYNX NV·Filed 2014·Application pending·0 cites
- 3650US2012253008A1Peptides capable of binding to serum proteins and compounds, constructs and polypeptides comprising the sameREVETS HILDE ADI PIERRETTE·Filed 2012·Application pending·0 cites
- 3740US2011243954A1Peptides capable of binding to serum proteins and compounds, constructs and polypeptides comprising the sameABLYNX NV·Filed 2011·Application pending·0 cites
- 3837US2015344568A1Techniques for predicting, detecting and reducing aspecific protein interference in assays involving immunoglobulin single variable domainsABLYNX NV·Filed 2015·Application pending·0 cites
- 3930US2011117113A1Immunoglobulin single variable domain directed against human cxcr4 and other cell associated proteins and methods to generate themBESTE GERALD·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Stephanie Staelens files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →